AT282821B - Verfahren zur Herstellung einer antigenfreien Vaccine - Google Patents

Verfahren zur Herstellung einer antigenfreien Vaccine

Info

Publication number
AT282821B
AT282821B AT576668A AT576668A AT282821B AT 282821 B AT282821 B AT 282821B AT 576668 A AT576668 A AT 576668A AT 576668 A AT576668 A AT 576668A AT 282821 B AT282821 B AT 282821B
Authority
AT
Austria
Prior art keywords
antigen
production
free vaccine
vaccine
free
Prior art date
Application number
AT576668A
Other languages
German (de)
English (en)
Inventor
Diether Dr Jachertz
Original Assignee
Diether Dr Jachertz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diether Dr Jachertz filed Critical Diether Dr Jachertz
Application granted granted Critical
Publication of AT282821B publication Critical patent/AT282821B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT576668A 1967-06-19 1968-06-17 Verfahren zur Herstellung einer antigenfreien Vaccine AT282821B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEJ0033936 1967-06-19

Publications (1)

Publication Number Publication Date
AT282821B true AT282821B (de) 1970-07-10

Family

ID=7204943

Family Applications (1)

Application Number Title Priority Date Filing Date
AT576668A AT282821B (de) 1967-06-19 1968-06-17 Verfahren zur Herstellung einer antigenfreien Vaccine

Country Status (13)

Country Link
AT (1) AT282821B (nl)
BE (1) BE716806A (nl)
BR (1) BR6899970D0 (nl)
CH (1) CH513241A (nl)
DE (1) DE1617545C2 (nl)
DK (1) DK119724B (nl)
ES (1) ES355121A1 (nl)
FR (2) FR1588820A (nl)
GB (1) GB1229888A (nl)
IE (1) IE32140B1 (nl)
IL (1) IL30168A (nl)
NL (1) NL6808486A (nl)
NO (1) NO124840B (nl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754934A (fr) * 1969-08-16 1971-02-17 Jachertz Diether Procede de production enzymatique d'arn-messager
GB1594097A (en) 1976-12-16 1981-07-30 Int Inst Of Differentiation Production of specific immune nucleic acids cell dialysates and antibodies
DE3115559A1 (de) * 1981-04-16 1982-10-28 Kommanditgesellschaft Schwarzhaupt, 5000 Köln Hochgereinigte informatorische ribonukleinsaeure (i-rns), verfahren zur herstellung und verwendung derselben
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system
US6214804B1 (en) 1989-03-21 2001-04-10 Vical Incorporated Induction of a protective immune response in a mammal by injecting a DNA sequence
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6673776B1 (en) 1989-03-21 2004-01-06 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
US6867195B1 (en) 1989-03-21 2005-03-15 Vical Incorporated Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected

Also Published As

Publication number Publication date
BE716806A (nl) 1968-12-19
FR7781M (nl) 1970-03-23
DK119724B (da) 1971-02-15
NO124840B (nl) 1972-06-12
BR6899970D0 (pt) 1973-02-13
CH513241A (de) 1971-09-30
FR1588820A (nl) 1970-03-16
NL6808486A (nl) 1968-12-20
IE32140L (en) 1968-12-19
ES355121A1 (es) 1969-11-16
IE32140B1 (en) 1973-04-18
GB1229888A (nl) 1971-04-28
IL30168A (en) 1973-05-31
DE1617545C2 (de) 1983-11-03
DE1617545A1 (de) 1971-04-01
IL30168A0 (en) 1968-08-22

Similar Documents

Publication Publication Date Title
AT281778B (de) Verfahren zur Herstellung von Alk-3-en-1-olen
AT283594B (de) Verfahren zur Herstellung von 7-Halogen-octopyranosiden
AT279602B (de) Verfahren zur Herstellung von Pyrrol-3-yl-ketonen
CH504421A (de) Verfahren zur Herstellung von Bis-thioureido-benzolen
AT282822B (de) Verfahren zur Herstellung adsorbierter Vakzinen
CH499541A (de) Verfahren zur Herstellung von Pyridyl-benzopyranen
CH502292A (de) Verfahren zur Herstellung von o-Isopropylaminobenzophenonen
AT282821B (de) Verfahren zur Herstellung einer antigenfreien Vaccine
CH507206A (de) Verfahren zur Herstellung substituierter 4-Aryl-3-hydroxybutyramide
CH545295A (de) Verfahren zur Herstellung von substituierten Benzimidazolen
AT283357B (de) Verfahren zur Herstellung von 2-Aryl-v-triazolen
CH502993A (de) Verfahren zur Herstellung von Ketonitrilen
CH483425A (de) Verfahren zur Herstellung von p-Alkoxy-piperidin-amiden
AT278001B (de) Verfahren zur Herstellung von N-Trityl-imidazolen
CH484930A (de) Verfahren zur Herstellung von Aryloxazolen
AT281420B (de) Verfahren zur Herstellung von α-Triorganosiloxy-ω-hydroxy-diorganopolysiloxanen
CH497438A (de) Verfahren zur Herstellung von Difluor-s-triazinen
AT280309B (de) Verfahren zur Herstellung von 3-Methansulfonylphenthiazinen
CH498114A (de) Verfahren zur Herstellung von 2-N-substituierten 2-Amino-5-nitropyridinen
AT284140B (de) Verfahren zur Herstellung von Pyrazinamidoguanidinen
CH496000A (de) Verfahren zur Herstellung von Benzimidazol-N-Oxyden
CH505784A (de) Verfahren zur Herstellung von 1-Brom-4-acylaminoanthrachinonen
CH504394A (de) Verfahren zur Herstellung von 6-Alkyl-citronellolen
CH499492A (de) Verfahren zur Herstellung von äthinylsubstituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
AT273369B (de) Verfahren zur Herstellung einer Röteln-Vaccine

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee